ID   BM13.1
AC   CVCL_B6V0
SY   BM 13.1
DR   cancercelllines; CVCL_B6V0
DR   Wikidata; Q111732967
RX   PubMed=3872842;
CC   Population: African; Kenyan.
CC   Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6UM ! BJAB-B95.8.6
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 6
//
RX   PubMed=3872842; DOI=10.1007/BF00375380;
RA   Spring B., Fonatsch C., Muller C., Pawelec G., Kompf J., Wernet P.,
RA   Ziegler A.;
RT   "Refinement of HLA gene mapping with induced B-cell line mutants.";
RL   Immunogenetics 21:277-291(1985).
//